SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042217
Filing Date
2021-08-09
Accepted
2021-08-06 17:36:26
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20210630.htm   iXBRL 10-Q 3691065
2 EX-10.2 stro-ex102_13.htm EX-10.2 39127
3 EX-31.1 stro-ex311_8.htm EX-31.1 17665
4 EX-31.2 stro-ex312_10.htm EX-31.2 16899
5 EX-32.1 stro-ex321_9.htm EX-32.1 6607
6 EX-32.2 stro-ex322_7.htm EX-32.2 6637
7 GRAPHIC glb04hcbyy2c000001.jpg GRAPHIC 58660
  Complete submission text file 0001564590-21-042217.txt   11915451

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA stro-20210630.xsd EX-101.SCH 68754
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20210630_cal.xml EX-101.CAL 44741
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20210630_def.xml EX-101.DEF 254880
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20210630_lab.xml EX-101.LAB 495012
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20210630_pre.xml EX-101.PRE 399457
13 EXTRACTED XBRL INSTANCE DOCUMENT stro-10q_20210630_htm.xml XML 2418645
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 211154005
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences